164 related articles for article (PubMed ID: 28125713)
1. Knockdown of Mediator Complex Subunit 19 Suppresses the Growth and Invasion of Prostate Cancer Cells.
Yu S; Wang Y; Yuan H; Zhao H; Lv W; Chen J; Wan F; Liu D; Gao Z; Wu J
PLoS One; 2017; 12(1):e0171134. PubMed ID: 28125713
[TBL] [Abstract][Full Text] [Related]
2. [Knockdown of mediator complex subunit 19 suppresses the migration and invasion and epithelial-mesenchymal transition in prostate cancer PC3 cells].
Zhang YL; Wang P; Zhang Y; Yu SS; Xu YK
Zhonghua Yi Xue Za Zhi; 2019 Nov; 99(42):3303-3307. PubMed ID: 31715665
[No Abstract] [Full Text] [Related]
3. Knockdown of mediator subunit Med19 suppresses bladder cancer cell proliferation and migration by downregulating Wnt/β-catenin signalling pathway.
Yuan H; Yu S; Cui Y; Men C; Yang D; Gao Z; Zhu Z; Wu J
J Cell Mol Med; 2017 Dec; 21(12):3254-3263. PubMed ID: 28631286
[TBL] [Abstract][Full Text] [Related]
4. Suppression of MED19 expression by shRNA induces inhibition of cell proliferation and tumorigenesis in human prostate cancer cells.
Cui X; Xu D; Lv C; Qu F; He J; Chen M; Liu Y; Gao Y; Che J; Yao Y; Yu H
BMB Rep; 2011 Aug; 44(8):547-52. PubMed ID: 21871180
[TBL] [Abstract][Full Text] [Related]
5. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z
Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia regulates ANXA1 expression to support prostate cancer cell invasion and aggressiveness.
Bizzarro V; Belvedere R; Migliaro V; Romano E; Parente L; Petrella A
Cell Adh Migr; 2017 May; 11(3):247-260. PubMed ID: 27834582
[TBL] [Abstract][Full Text] [Related]
7. Gastrin-releasing peptide receptor (GRPr) promotes EMT, growth, and invasion in canine prostate cancer.
Elshafae SM; Hassan BB; Supsavhad W; Dirksen WP; Camiener RY; Ding H; Tweedle MF; Rosol TJ
Prostate; 2016 Jun; 76(9):796-809. PubMed ID: 26939805
[TBL] [Abstract][Full Text] [Related]
8. Disruption of mediator complex subunit 19 (Med19) inhibits cell growth and migration in tongue cancer.
Zhu LJ; Yan WX; Chen ZW; Chen Y; Chen D; Zhang TH; Liao GQ
World J Surg Oncol; 2013 May; 11():116. PubMed ID: 23705783
[TBL] [Abstract][Full Text] [Related]
9. Expression of Med19 in bladder cancer tissues and its role on bladder cancer cell growth.
Zhang H; Jiang H; Wang W; Gong J; Zhang L; Chen Z; Ding Q
Urol Oncol; 2012; 30(6):920-7. PubMed ID: 21478038
[TBL] [Abstract][Full Text] [Related]
10. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
[TBL] [Abstract][Full Text] [Related]
11. MED19 alters AR occupancy and gene expression in prostate cancer cells, driving MAOA expression and growth under low androgen.
Weber H; Ruoff R; Garabedian MJ
PLoS Genet; 2021 Jan; 17(1):e1008540. PubMed ID: 33513133
[TBL] [Abstract][Full Text] [Related]
12. SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin.
Deep G; Jain AK; Ramteke A; Ting H; Vijendra KC; Gangar SC; Agarwal C; Agarwal R
Mol Cancer; 2014 Feb; 13():37. PubMed ID: 24565133
[TBL] [Abstract][Full Text] [Related]
13. The biological functions and mechanism of miR‑212 in prostate cancer proliferation, migration and invasion via targeting Engrailed-2.
Zhou Y; Ji Z; Yan W; Zhou Z; Li H
Oncol Rep; 2017 Sep; 38(3):1411-1419. PubMed ID: 28713997
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of mediator complex subunit 19 inhibits the growth of ovarian cancer.
Liu Y; Tao X; Fan L; Jia L; Gu C; Feng Y
Mol Med Rep; 2012 Nov; 6(5):1050-6. PubMed ID: 22961438
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
[TBL] [Abstract][Full Text] [Related]
16. MED19 promotes proliferation and tumorigenesis of lung cancer.
Sun M; Jiang R; Li JD; Luo SL; Gao HW; Jin CY; Shi DL; Wang CG; Wang B; Zhang XY
Mol Cell Biochem; 2011 Sep; 355(1-2):27-33. PubMed ID: 21519921
[TBL] [Abstract][Full Text] [Related]
17. MED19 encodes two unique protein isoforms that confer prostate cancer growth under low androgen through distinct gene expression programs.
Ruoff R; Weber H; Wang Y; Huang H; Shapiro E; Fenyö D; Garabedian MJ
Sci Rep; 2023 Oct; 13(1):18227. PubMed ID: 37880276
[TBL] [Abstract][Full Text] [Related]
18. Lentivirus-mediated inhibition of Med19 suppresses growth of breast cancer cells in vitro.
Li LH; He J; Hua D; Guo ZJ; Gao Q
Cancer Chemother Pharmacol; 2011 Jul; 68(1):207-15. PubMed ID: 20890603
[TBL] [Abstract][Full Text] [Related]
19. SOX4 induces tumor invasion by targeting EMT-related pathway in prostate cancer.
Liu Y; Zeng S; Jiang X; Lai D; Su Z
Tumour Biol; 2017 May; 39(5):1010428317694539. PubMed ID: 28466783
[TBL] [Abstract][Full Text] [Related]
20. CC-chemokine receptor 7 is overexpressed and correlates with growth and metastasis in prostate cancer.
Chen Y; Tian Y; Ji Z; Liu Z; Shang D
Tumour Biol; 2015 Jul; 36(7):5537-41. PubMed ID: 25682287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
